Will Sanofi and Regeneron's Dupixent be a game-changer for COPD?
Amazon closes blockbuster deal with One Medical
FDA's Robert Califf calls on insurers to help providers participate in critical clinical drug trials
Karuna’s schizophrenia drug succeeds in a second late-stage trial
*please scroll down for all the latest news*